MENU
+Compare
PRTA
Stock ticker: NASDAQ
AS OF
Dec 24 closing price
Price
$9.69
Change
+$0.20 (+2.11%)
Capitalization
521.61M

PRTA Prothena Corp Forecast, Technical & Fundamental Analysis

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases... Show more

Industry: #Biotechnology
PRTA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for PRTA with price predictions
Dec 24, 2025

PRTA in downward trend: price dove below 50-day moving average on December 15, 2025

PRTA moved below its 50-day moving average on December 15, 2025 date and that indicates a change from an upward trend to a downward trend. In of 37 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 09, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PRTA as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for PRTA turned negative on December 09, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for PRTA crossed bearishly below the 50-day moving average on December 17, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRTA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PRTA broke above its upper Bollinger Band on December 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 71 cases where PRTA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PRTA advanced for three days, in of 293 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 162 cases where PRTA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PRTA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.768) is normal, around the industry mean (26.541). P/E Ratio (0.000) is within average values for comparable stocks, (51.479). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.873). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (44.248) is also within normal values, averaging (311.015).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
PRTA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

PRTA is expected to report earnings to fall 17.85% to -55 cents per share on February 12

Prothena Corp PRTA Stock Earnings Reports
Q4'25
Est.
$-0.56
Q3'25
Beat
by $0.04
Q2'25
Missed
by $1.12
Q1'25
Beat
by $0.11
Q4'24
Missed
by $0.08
The last earnings report on November 06 showed earnings per share of -68 cents, beating the estimate of -72 cents. With 237.36K shares outstanding, the current market capitalization sits at 521.61M.
A.I. Advisor
published General Information

General Information

a developer of novel antibodies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
77 Sir John Rogerson’s Quay
Phone
+353 12362500
Employees
173
Web
https://www.prothena.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PREPX26.740.16
+0.60%
Principal Real Estate Securities R5
LFGAX42.500.07
+0.16%
Lord Abbett Focused Growth A
CAISX11.240.01
+0.09%
Calamos International Small Cap Gr A
FCLCX44.62N/A
N/A
Fidelity Advisor Industrials C
FEQJX14.98N/A
N/A
Fidelity Advisor Hedged Equity I

PRTA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PRTA has been loosely correlated with RCKT. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if PRTA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTA
1D Price
Change %
PRTA100%
+2.11%
RCKT - PRTA
53%
Loosely correlated
+1.74%
SVRA - PRTA
48%
Loosely correlated
-0.62%
CADL - PRTA
38%
Loosely correlated
+3.58%
AXON - PRTA
38%
Loosely correlated
+0.02%
DNLI - PRTA
37%
Loosely correlated
+1.07%
More